Packaging pre-production specialist, Esko has launched a new
programme that it claims will streamline the pharma packaging
process and bring new products to market up to 40 per cent faster.
A new confocal imaging module for applications such as 3D map
microfluidics analysis has been launched, which will aid all phases
of microfluidics development, from understanding physical phenomena
in the lab through developing novel...
German biopharma firm Sandoz has won a landmark first-of its-kind
biosimilar drug approval in the US after a long battle with the US
Food and Drug Administration (FDA). The decision could open the
floodgates for generics manufacturers...
Effective resource allocation and portfolio designs are vital to a
drug company's financial survival as backing the wrong product can
waste millions of dollars and vital development time.
As demand for protein-based drugs increases, Pall has introduced a
new type of mixed-mode chromatography sorbents that make protein
purification faster and cheaper.
German packaging firm Gerresheimer has ventured further into China,
buying a majority interest in Chinese pharmaceutical packager
Shuangfeng Group and gaining entry into the Chinese market for
tubular glass packaging for the first...
A new e-learning course promises to cover everything one needs to
know about demanding current good manufacturing practice (cGMP)
topics such as standard operating procedures (SOPs).
SAFC Supply Solutions has introduced new phosphoramidites and
ancillary reagents for oligonucleotide (oligo) synthesis, promising
consistent quality, tight specifications and reliability.
Canadian contract manufacturer Patheon saw pre-tax profits remain
idle in the second quarter of 2006, leaving it struggling to find
ways to boost profitability.
deltaDOT launches a unique capillary-based DNA sequencer that has
been specifically developed to provide a low-cost rapid throughput
DNA sequencing solution in numerous drug discovery applications.
Thermo Electron has announced the availability of further
enhancements to its Galileo LIMS, which aims to provide additional
capabilities for high throughput ADMET experiments that facilitate
lead optimisation in drug discovery.
Determined to eradicate a disease that takes the lives of more than
one million people worldwide each year, Novartis has announced it
will participate in a new public-private partnership which aims to
discover more potent drugs to...
Medidata Solutions has opened a new clinical data centre and
enlisted the help of consultancy firm C3i to provide its customers
with faster and more secure electronic clinical trial support as
demand for these services continues to...
MAP Pharmaceuticals has awarded the manufacturing of the
metered-dose components of its new inhaler devices to Xemplar, who
is one of the few contract manufacturers in the world that can take
on such a challenge and is now upping...
Troubled contract sales and marketing firm PDI has recently won a
much-needed new sales contract and made two new top executive
appointments as part of ongoing efforts to turn its flagging
business around.
Pro Mach, one of the largest providers of packaging products,
services and integrated solution sets in North America, has
acquired Allpax Products, a manufacturer of sterilisation, material
handling and automated control systems for...
China could be the first country to conduct human stem cell trials
and presents a significant opportunity for Western companies who
are brave enough to use this risky destination as a place to pursue
this potentially lucrative sector...
In a scathing letter to Wyeth, the US Food and Drug Administration
(FDA) has vehemently criticised the drugmaker's manufacturing
operations in Puerto Rico, accusing it of failing to report
failures even when it was aware of them.
Determined to transform itself from a chemical distributor to a
drug firm, Schweizerhall has sold its chemical business unit to
Brenntag for SFr93m (€60m), allowing it to pay for financial
obligations, invest in its pharma division,...
RSSL Pharma Training has established three new courses to help UK
pharmaceutical and medical device manufacturers prepare themselves
for a plant inspection by the US Food and Drug Administration
(FDA).
The gastrointestinal (GI) market is one of the largest in the
pharma industry and continues to attract a high level of R&D
investment, however, the market has recently entered a crucial
phase, with mounting commercial pressures...
Those in the regulatory affairs profession can now breathe a sigh
of relief as the industry-recognised accreditation process just got
a whole lot easier.
The stage is ready for the biggest acquisition in BASF's 140-year
history after Engelhard's management agreed to recommend their
shareholders accept the German chemical group's $5bn (€3.8bn)
takeover bid.
In what it claims is the largest investment to date by any
multinational drug company in China, AstraZeneca will spend $100m
(€77.6m) on research and development in the country over the next
three years, targeting primarily the domestic...
Sigma-Aldrich introduces its signal transduction protein array for
high-throughput functional screening, which is set to play a major
role in identifying proteins that are involved in cellular
processes including proliferation, differentiation...
Particle Measuring Systems have fitted its portable
airborne-particle counter with what it claims is the longest
lasting laser on the market, as well as new features that allow it
to calculate and create reports for EC GMP Annex #1,...
The University of Kentucky has unveiled the state's largest sterile
pharmaceutical manufacturing site which is unique among others
worldwide as it is the first to produce cytotoxic and non-cytotoxic
drugs in the same room at...
Cardinal Health is about to embark on a first-of-its-kind
radiofrequency identification (RFID) tag pilot that tests the
viability of the new technology across the entire supply chain,
from item throughout to case and pallet level.
Although clearing Parexel from contributing to the recent drug
trial disaster, a final UK Medicines and Healthcare products
Regulatory Agency (MHRA) report slammed the US firm for making a
number of basic errors during the trial process.
Millipore has made available Protein Blotting Sandwiches that offer
convenience and time savings for high throughput labs using
chemiluminescent or chromogenic detection methods.
BASF is targeting the pharma industry at ChemSpec this June with
new intermediates, catalysts and raw materials that promise to make
customers' syntheses less complex and time-consuming as well as
more cost-effective.
UK-based Malvern Instruments has been busy streamlining its
particle characterisation contract testing services at its global
locations, with the latest reshuffle taking place in France.
MFIC Corporation, whose Microfluidics Division manufactures
industrial submicron processing equipment, has returned to
profitability in the first quarter of 2006 after big losses in
first quarter of last year, buoyed by increased...
IT services company HCL Technologies continues to experience rapid
growth through its ability to undercut clinical research
organisations (CROs) on price for clinical data management (CDM)
services through its new operations in India.
The Tampa-based formulation development laboratory of MDS Pharma
Services has split from its parent company and formed a new firm
with the technology to get active pharmaceutical ingredients (APIs)
directly into capsules.
India's Dishman Pharmaceuticals & Chemicals has snapped up the
Swiss-based pharmaceutical services business, Carbogen and Amcis,
of financially-troubled US chemical firm Solutia for the sum of
$74.5m (€58m).
Microbia has presented clinical data that shows its first-in-class
drug for the treatment of constipation-predominant irritable bowel
syndrome (IBS-C) and chronic constipation (CC), demonstrated
promising pharmacodynamic effects.
A new drug discovery approach, which essentially reverses the
process of drug compound screening promises a increased efficiency
in drug discovery whilst keeping costs down to a minimum.
According to a new report, the European central nervous system
therapeutic market is set to capitalise on an ageing population, a
high level of unmet clinical need and increasing prevalence of
neurological disorders, growing to $31.31bn...
Cisbio has introduced its second IP-One assay, which can be used by
all laboratories focused on GPCR-based targets of which 45 per cent
of currently marketed drugs owe their efficacy to.
Accium BioSciences and Quintiles Transnational has established an
agreement, which intends to offer turnkey Exploratory-IND,
Microdosing and Information-Rich Phase I clinical trials services
to biopharmaceutical researchers.
Registration is now open for the annual "Pharmaceutical Outsourcing
of Discovery Chemistry, Advanced Intermediates and API's"
conference, which this year celebrates its 10th anniversary.
US biotech company Spherix has selected Singapore-based clinical
research organisation (CRO) Gleneagles to take charge of the Phase
III clinical trial program for its new Type 2 diabetes drug,
Naturlose.
Bioprogress has signed a development agreement with emerging
speciality pharmaceutical company Uluru to combine their film
technologies in order to create an edible film which allows
sustained release of active ingredients.
Matritech has introduced the first urine test that indicates
whether a bladder malignancy is likely to be dangerous, providing
early identification of high-risk tumours and therefore increasing
the success of subsequent treatment.
Biophan has filed the first patent to come out of its newly-formed
relationship with NaturalNano to develop new and improved ways of
controlled-release drug delivery.
Life sciences firm Cambrex has agreed a contract for the production
of clinical trial quantities of Merrimack Pharmaceuticals'
recombinant immunomodulatory serum protein, as its experience in
the downstream purification of proteins...
India's Ranbaxy Laboratories has stepped up its efforts to dominate
the domestic novel drug delivery system (NDDS) market, in-licensing
two new drugs from Europe in as many weeks.
The World Health Organization (WHO) has announced details of a new
initiative compelling drug companies to register all clinical
trials on humans after public pressure for more transparency.
